on The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has released a Form 8.3 disclosure regarding its stake in Spire Healthcare Group plc. The disclosure, dated 24 September 2026, outlines Vanguard's interest in relevant securities of Spire Healthcare. According to the data, Vanguard holds 14,398,185 shares, accounting for 3.57% of Spire's ordinary shares.
The document specifies the transaction date as 23 September 2026 and indicates minimal recent activity with a purchase of 199 shares at a price of 2.46 GBP each. Vanguard discloses no open derivative positions or additional dealings related to Spire. There are no new subscription rights, other dealings, or agreement arrangements influencing its current stake.
The public disclosure is part of compliance with Rule 8.3 of the Takeover Code, ensuring transparency in relevant security interests exceeding 1%.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news